By using in silico models of the complexes formed by analogues of a cancer drug and its receptor, it may be possible to strategically redesign existing drugs and win the race against mutations that lead to drug resistance in prostate cancer.
Keywords: Human; Mouse; androgen receptor; drug resistance; prostate cancer.